Updates to the ASH guidelines on VTE: Thrombophilia testing and anticoagulation in COVID-19 patients

KRd offers durable survival benefits among patients with transplant-ineligible multiple myeloma

Ruxolitinib exhibits sustained efficacy compared to best available treatment in patients with chronic GvHD: 3-year final analysis of the REACH3 study

Contextualizing the advantages of early intervention in HR-SMM

Revised definition of LC-MGUS with FLC measurements stratified by age: The iStopMM study

Re-classifying the risk of patients with multiple myeloma using novel staging systems: Results from a nationwide US-based cohort study

Mosunetuzumab demonstrates consistent efficacy in patients with R/R follicular lymphoma after ≥2 prior treatments: 3-year follow-up from a pivotal phase 2 study